BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Adipose tissue
,
Metabolism of nitric oxide
,
Bleomycin
,
rs3825942
,
BRAF
,
HIV infection
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
RORγt
Summary
General Info
Curated Studies
Most Correlated Studies
Innate lymphoid cells (ILCs) stimulated with cytokines and/or NKp44 antibody
CD4+ T-lymphocytes (Th17) treated with RORgt inhibitors and lymphocytes from RORC cKO mice
Th17 cell differentiation in RORyt-deficient T cells treated with or without digoxin
T helper cells TH17 with RMRPG262T knock-in, DDX5 or RORg knockout
CD4+ T helper lymphocyte subtypes
Explore Curated Studies Results
Literature
Most Relevant Literature
The emerging family of RORγt+ antigen-presenting cells.
Small molecule inhibitors of RORγt for Th17 regulation in inflammatory and autoimmune diseases.
Alcohol-driven metabolic reprogramming promotes development of RORγt-deficient thymic lymphoma.
An embarrassment of riches: RORγt+ antigen-presenting cells in peripheral tolerance.
The CCR6/CCL20 axis expands RORγt+ Tregs to protect from glomerulonephritis.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
The Immunomodulatory Effects of Oral Nanocurcumin in Multiple Sclerosis Patients
The Effects of Nanocurcumin on Treg Cells and Th17 Cells Responses in Ankylosing Spondylitis Patient…
A Multipeptide Vaccine Plus Toll-Like Receptor Agonists in Melanoma Patients
Can Gluten-free Diet Prevent the Destruction of Beta-cells During Remission?
Immunomodulation With Romiplostim in Young Adults With ITP
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ